Exempting drugmakers that struck voluntary price deals from the mandatory pricing model undermines the program

The companies that cooperated with the White House on voluntary cuts get a pass on the mandatory model everyone else must follow.

From the articleTrump Administration Finalizes Plan to Lower Drug Prices in MedicareAlso in Trump's watered-down Medicare drug pricing rule saves 96% less than initial proposal, CMS Finalizes New Mandatory Drug Payment Model to Deliver Lower Drug Prices for Beneficiaries in Original Medicare Part B